Katrin Baer

Title: The Innovative Contributions of Katrin Baer

Introduction

Katrin Baer is a notable inventor based in Mainz, Germany. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of glycine transport inhibitors. Her work exemplifies the intersection of innovation and practical application in the medical industry.

Latest Patents

Katrin Baer holds a patent for a process of reworking a crystalline form of a glycine transport inhibitor. The invention describes a process for reworking a crystallization product that involves drying and homogenization. The crystallization product is identified as crystalline [5-(methylsulfonyl)-2-{[(2R)-1,1,1-trifluoropropan-2-yl]oxy}phenyl]{(1R,5R)-1-[5-(trifluoromethyl)-1,2-oxazol-3-yl]-3-azabicyclo[3.1.0]hex-3-yl}methanone. The product is dried in a tray dryer or in a pan dryer and subsequently homogenized. This innovative process enhances the efficiency and effectiveness of the glycine transport inhibitor.

Career Highlights

Katrin Baer is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. Her role at the company allows her to contribute to groundbreaking research and development in the pharmaceutical sector. With her expertise, she plays a vital role in advancing medical treatments and therapies.

Collaborations

Katrin has collaborated with several talented individuals in her field, including Julia Regina Grimm and Albert Josef Barta. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective projects.

Conclusion

Katrin Baer is a remarkable inventor whose work in the pharmaceutical industry has led to valuable innovations. Her patent on the reworking of glycine transport inhibitors showcases her commitment to improving medical treatments. Through her career at Boehringer Ingelheim International GmbH, she continues to make impactful contributions to science and healthcare.